The global economic burden of COVID-19 disease: a comprehensive systematic review and meta-analysis
Systematic Reviews · 16.02.2024 · 13 (1)
DOI: 10.1186/s13643-024-02476-6 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Systematic Reviews, online erschienen am 16.02.2024. Verfasst von Ahmad Faramarzi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Economics and Management, School of Public Health, Urmia University of Medical Sciences, Urmia, Iran. ahmadfaramarzi97@yahoo.com. Hauptthemen laut MEDLINE: COVID-19, Cost of Illness, SARS-CoV-2, Global Health. Die Arbeit wurde bisher 100-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The COVID-19 pandemic has caused a considerable threat to the economics of patients, health systems, and society.
Objectives
This meta-analysis aims to quantitatively assess the global economic burden of COVID-19.
Methods
A comprehensive search was performed in the PubMed, Scopus, and Web of Science databases to identify studies examining the economic impact of COVID-19. The selected studies were classified into two categories based on the cost-of-illness (COI) study approach: top-down and bottom-up studies. The results of top-down COI studies were presented by calculating the average costs as a percentage of gross domestic product (GDP) and health expenditures. Conversely, the findings of bottom-up studies were analyzed through meta-analysis using the standardized mean difference.
Results
The implemented search strategy yielded 3271 records, of which 27 studies met the inclusion criteria, consisting of 7 top-down and 20 bottom-up studies. The included studies were conducted in various countries, including the USA (5), China (5), Spain (2), Brazil (2), South Korea (2), India (2), and one study each in Italy, South Africa, the Philippines, Greece, Iran, Kenya, Nigeria, and the Kingdom of Saudi Arabia. The results of the top-down studies indicated that indirect costs represent 10.53% of GDP, while the total estimated cost accounts for 85.91% of healthcare expenditures and 9.13% of GDP. In contrast, the bottom-up studies revealed that the average direct medical costs ranged from US $1264 to US $79,315. The meta-analysis demonstrated that the medical costs for COVID-19 patients in the intensive care unit (ICU) were approximately twice as high as those for patients in general wards, with a range from 0.05 to 3.48 times higher.
Conclusions
Our study indicates that the COVID-19 pandemic has imposed a significant economic burden worldwide, with varying degrees of impact across countries. The findings of our study, along with those of other research, underscore the vital role of economic consequences in the post-COVID-19 era for communities and families. Therefore, policymakers and health administrators should prioritize economic programs and accord them heightened attention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Health Economics and Management, School of Public Health, Urmia University of Medical Sciences, Urmia, Iran. ahmadfaramarzi97@yahoo.com.
- Department of Health Economics and Management, School of Public Health, Urmia University of Medical Sciences, Urmia, Iran.
- Department of Medical Library and Information Science, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran.
- Social Determinants of Health Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
ORCID-Profile: Ahmad Faramarzi, Soheila Norouzi
Zitieren
APA
Faramarzi, A., Norouzi, S., Dehdarirad, H., Aghlmand, S., Yusefzadeh, H., & Javan-Noughabi, J. (2024). The global economic burden of COVID-19 disease: a comprehensive systematic review and meta-analysis. Systematic Reviews, 13(1). https://doi.org/10.1186/s13643-024-02476-6
Vancouver
Faramarzi A, Norouzi S, Dehdarirad H, Aghlmand S, Yusefzadeh H, Javan-Noughabi J. The global economic burden of COVID-19 disease: a comprehensive systematic review and meta-analysis. Systematic Reviews. 2024;13(1). doi:10.1186/s13643-024-02476-6
BibTeX
@article{Faramarzi2024,
author = {Faramarzi, Ahmad and Norouzi, Soheila and Dehdarirad, Hossein and Aghlmand, Siamak and Yusefzadeh, Hasan and Javan-Noughabi, Javad},
title = {The global economic burden of COVID-19 disease: a comprehensive systematic review and meta-analysis},
journal = {Systematic Reviews},
year = {2024},
volume = {13},
number = {1},
doi = {10.1186/s13643-024-02476-6}
}
EUVIMED